The Outcome of Lupus Nephritis in Jamaican Patients
- 31 December 2007
- journal article
- Published by Elsevier BV in The American Journal of the Medical Sciences
- Vol. 334 (6), 426-430
- https://doi.org/10.1097/maj.0b013e3180de4997
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- The clinical and epidemiologic features in 140 patients with lupus nephritis in a predominantly black population from one center in Kingston, Jamaica.The American Journal of the Medical Sciences, 2004
- Severity of systemic lupus erythematosus with diffuse proliferative glomerulonephritis and the ineffectiveness of standard pulse intravenous cyclophosphamide therapy in Jamaican patients.Lupus, 2003
- Therapy of membranous nephropathy in systemic lupus erythematosusSeminars in Nephrology, 2003
- Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black AmericansKidney International, 1997
- Methylprednisolone and Cyclophosphamide, Alone or in Combination, in Patients with Lupus NephritisAnnals of Internal Medicine, 1996
- Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritisThe Lancet, 1992
- Therapy of Lupus NephritisThe New England Journal of Medicine, 1986
- Membranous Glomerulonephropathy with Crescents in Systemic Lupus erythematosusAmerican Journal of Nephrology, 1985
- Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcomeKidney International, 1984
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982